Clinical Research

Tarchominskie Zaklady Farmaceutyczne Polfa S.A.

Address
Ul. Aleksandra Fleminga 2

Sponsor Overview

assignment
7
sponsored trials
science
3
molecules
location_city
3
research centres
public
1
country
person_search
4
investigators

Specializations

Bioequivalence and pharmacokinetic research

The sponsor’s clinical programme is centred on bioequivalence studies in healthy volunteers, with a strong focus on comparing oral formulations and establishing pharmacokinetic similarity for marketed and generic medicines.

  • Healthy volunteer studies
  • Fed and fasting conditions
  • Oral solid and oral suspension formulations

These studies support development work for antibacterial, antidiabetic, and other systemic therapies.

Antibacterial therapy

A major therapeutic area of interest is anti-infective treatment, particularly medicines used against bacterial infections and serious gram-negative pathogens.

  • Amoxicillin and clavulanic acid
  • Colistimethate sodium
  • Serious bacterial infections

The sponsor’s research activity reflects continued attention to established antibiotic combinations and agents for limited-treatment-option settings.

Metabolic and endocrine medicines

The sponsor also funds clinical research in type 2 diabetes mellitus, with attention to SGLT2 inhibitor therapies used in routine metabolic care.

  • Dapagliflozin
  • Empagliflozin
  • Insufficiently controlled type 2 diabetes

This area links the company’s formulation research with medicines used for long-term glycaemic control.

Cardiorenal disease

Another area of interest includes therapies relevant to symptomatic chronic heart failure and chronic kidney disease, both of which are important targets for modern cardiorenal treatment strategies.

  • Heart failure
  • Chronic kidney disease
  • Cardiorenal medicine

Research activity in this domain aligns with medicines that are used across overlapping cardiovascular and renal indications.

Sponsored Trials

Trial Name Country Status
A Bioequivalence Study of Empagliflozin in Healthy ParticipantsCzechia CzechiaNot Recruiting
A Randomized, Open-Label, Two-Period, Two-Sequence, Crossover Bioequivalence Study of Amoxicillin-Clavulanate Film-Coated Tablets in Healthy Volunteers Under Fed ConditionsCzechia CzechiaNot Recruiting
Bioequivalence Study of Amoxicillin and Clavulanic Acid Oral Suspension in Healthy Volunteers Under Fed ConditionsCzechia CzechiaNot Recruiting
Bioequivalence Study of Amoxicillin/Clavulanic Acid Formulations in Healthy Volunteers Under Fed ConditionsCzechia CzechiaNot Recruiting
Bioequivalence Study of Amoxicillin/Clavulanic Acid Powder for Oral Suspension in Healthy Adults Under Fed ConditionsCzechia CzechiaNot Recruiting
Bioequivalence Study of Dapagliflozin 10 mg Tablets in Healthy Volunteers for Type 2 Diabetes, Chronic Heart Failure, and Chronic Kidney DiseaseCzechia CzechiaNot Recruiting
Pharmacokinetic Evaluation of Colistimethate Sodium in Treating Serious Infections by Aerobic Gram-Negative Pathogens in Patients with Limited Treatment OptionsCzechia CzechiaNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 3 total (0% not shared with other sponsors)

This sponsor works with 3 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
67%
Return partnership rate
2 of 3 sites collaborated multiple times

This sponsor has worked with 3 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Bacterial Infections and Mycoses5 trials
    180 other sponsors
  • 2.
    Cardiovascular Diseases1 trial
    359 other sponsors
  • 3.
    Hormonal diseases1 trial
    89 other sponsors
  • 4.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors

Partnered Research Centres

3 centres
location_city
assignment24
Cepha s.r.o.
Address
Komenskeho 19, Severni Predmesti, 323 00 Pilsen
Learn morearrow_forward
location_city
assignment42
Quinta-Analytica s.r.o.
Address
Prazska 1486/18c, Hostivar, 102 00 Prague
Learn morearrow_forward
location_city
assignment7
Quinta-Analytica s.r.o.
Address
Umelecka 305/1, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Tarchominskie Zaklady Farmaceutyczne Polfa S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.